Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With Tc-Labeled Duramycin SPECT/CT
Our goal was to validate the feasibility of 99m Tc-duramycin as a potential apoptosis probe for monitoring tumor response to paclitaxel in breast cancer xenografts. The binding of 99m Tc-duramycin to phosphatidylethanolamine was validated in vitro using paclitaxel-treated human breast carcinoma MDA-...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi - SAGE Publishing
2016-01-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.1177/1536012115624918 |